Clinical Trials
3 trialsNCT01032070 2024-12-12
PETEY
Astellas Pharma Inc
Phase 2 Terminated
NCT01247922 2024-12-06
Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205
Astellas Pharma Inc
Phase 2 Terminated
NCT00004212 2012-05-16
DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
Daiichi Sankyo
Phase 1 Completed